Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343525
Status:
COMPLETED
Last Update Posted:
2008-05-07
First Post:
2006-06-21
Brief Title:
Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C
Sponsor:
Peregrine Pharmaceuticals
Organization:
Peregrine Pharmaceuticals
Organization Data
Organization:
Peregrine Pharmaceuticals
Class:
INDUSTRY
Study ID:
PPHM 0601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peregrine Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dianne UphoffSenior Clinical Project Manager
Old Organization:
Peregrine Pharmaceuticals